Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
about
In vitro-activated tumor-specific T lymphocytes prolong the survival of patients with advanced gastric cancer: a retrospective cohort studyPromising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune PathwaysDesirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells.Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor DevelopmentFluorescent nanodiamonds engage innate immune effector cells: A potential vehicle for targeted anti-tumor immunotherapy.N-carboxyanhydride polymerization of glycopolypeptides that activate antigen presenting cells through Dectin-1 and -2.Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion.Hypoxia restrains the expression of complement component 9 in tumor-associated macrophages promoting non-small cell lung cancer progression.
P2860
Q37042451-FB5ED05C-4F74-4A1D-B606-1D5569A7DE49Q37690959-FC2F6CBC-72B7-4FC6-9FBF-A25518612CFDQ39014899-75C11AEE-5E32-4B46-B63B-75FB789D40F5Q41343761-680236DB-DC1B-425C-8F3E-AF4596F0A071Q41684112-00317AD6-CAB5-4CDC-86CF-B62070E9B58DQ47782526-242C4CC2-BC36-4B79-9603-A0EFD04D3F0BQ49690970-CE86A9C2-CB42-43B3-B7A6-72668ECE03E0Q52716912-9335DA06-C780-48CB-B09C-4AE21B246A98Q55024293-500969D4-8544-4FAD-8707-C0549B340627
P2860
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
@ast
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
@en
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
@nl
type
label
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
@ast
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
@en
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
@nl
prefLabel
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
@ast
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
@en
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
@nl
P2860
P3181
P1433
P1476
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
@en
P2093
Jacob L Goldberg
Paul M Sondel
P2860
P304
P3181
P356
10.1053/J.SEMINONCOL.2015.05.012
P407
P577
2015-08-01T00:00:00Z